SCHEMBL79535

SCHEMBL79535

O=P(Oc1cc2c(Cl)c(Br)ccc2[nH]1)(Oc1cc2c(Cl)c(Br)ccc2[nH]1)Oc1cc2c(Cl)c(Br)ccc2[nH]1

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
DAO P14920 1/20 0.32
GPER1 Q99527 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29377568 0.88 DAO (0.31) DAO
SCHEMBL79536 0.88 DAO (0.33) DAO
SCHEMBL7749525 0.88 DAO (0.31) DAO
SCHEMBL4084854 0.83 TDP1 (0.38)
SCHEMBL4084856 0.81 CA2 (0.36)
SCHEMBL9010844 0.78 DAO (0.32) DAO
Tetrazole SCHEMBL5041698 0.77
Tetrazole SCHEMBL5041695 0.77
SCHEMBL6140846 0.77 ALDH1A1 (0.33)
Tetrazole SCHEMBL3922918 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090253134-A1 Cellular Pyrogen Test FRAUNHOFER-GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) 2009-10-08 US claimed
US-5264098-A Method for the separation, identification and quantification of isoenzymes and isoforms of alkaline phosphatase ANALIS S.A. (BE) 1993-11-23 US claimed
EP-0495346-A1 Procedure for separation, identification, and quantification of isoenzymes and isoforms of the alkaline phosphatase ANALIS S.A. (BE) 1992-07-22 EP claimed
US-20250064927-A1 COMPOSITIONS COMPRISING CROSS-SPECIES-SPECIFIC ANTIBODIES AND USES THEREOF AMGEN RESEARCH (MUNICH) GMBH (DE) 2025-02-27 US disclosed
US-20240310377-A1 EVALUATION, ASSAYS AND TREATMENT OF PKALMEDIATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2024-09-19 US disclosed
EP-2588219-B1 FILTER PLATE ARTICLE HAVING A WATER-ABSORBENT FILTER ASSEMBLY NEOGEN FOOD SAFETY US HOLDCO CORP (US) 2024-05-29 EP disclosed
US-11925684-B2 Compositions comprising cross-species-specific antibodies and uses thereof AMGEN RESEARCH (MUNICH) GMBH (DE) 2024-03-12 US disclosed
US-11892450-B2 Evaluation, assays and treatment of pKal-mediated disorders TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2024-02-06 US disclosed
CN-110208533-B Evaluation, determination and treatment of PKAL-mediated disorders 武田药品工业株式会社 2023-01-10 CN disclosed
US-9885089-B2 Flagellum and anti-flagellum antibody levels in samples as a diagnostic biomarker and therapeutic target for metabolic syndrome CORNELL UNIVERSITY (US) 2018-02-06 US disclosed
EP-2519821-B1 MICROBIAL DETECTION ARTICLE 3M INNOVATIVE PROPERTIES CO (US) 2016-11-30 EP disclosed
WO-1995034660-A1 MODIFICATION OF STARCH CONTENT IN PLANTS ADVANCED TECHNOLOGIES (CAMBRIDGE) LIMITED (GB) 1995-12-21 WO disclosed
EP-0681609-A1 A PROCESS FOR THE PREPARATION OF LIPASE NOVO NORDISK A/S (DK) 1995-11-15 EP disclosed
US-5457089-A Treating renal anemia BEHRINGWERKE AKTIENGESELLSCHAFT (DE) 1995-10-10 US disclosed
WO-1995004145-A1 NOVEL B. BURGDORFERI POLYPEPTIDES YALE UNIVERSITY (US) 1995-02-09 WO disclosed
WO-1994017211-A1 NON-RADIOACTIVE METHOD FOR DETECTING A LABELLED SEGMENT AND A SOLUTION OR COMPOSITION THEREFOR WRIGHT DENNIS (US) 1994-08-04 WO disclosed
WO-1994003601-A9 CLONING, EXPRESSION AND USES FOR NEUROCAN AS A CHONDROITIN SULFATE PROTEOGLYCAN 1994-03-31 WO disclosed
WO-1994003601-A2 CLONING, EXPRESSION AND USES FOR NEUROCAN AS A CHONDROITIN SULFATE PROTEOGLYCAN NEW YORK UNIVERSITY (US) 1994-02-17 WO disclosed
WO-1993013200-A1 A PROCESS FOR THE PREPARATION OF LIPASE NOVO NORDISK A/S (DK) 1993-07-08 WO disclosed
EP-0298450-A2 Hybridoma cell lines, monoclonal antibodies and their use for immunocytochemical detection or fluorescence-activated sorting of cells expressing the c-myb protein and pharmaceutical compositions Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 1989-01-11 EP disclosed